Journey Medical Corporation (NASDAQ:DERM) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET
Company Participants
Jaclyn Jaffe - Senior Director, Corporate Operations
Claude Maraoui - Co-Founder, President and CEO
Joseph Benesch - Interim Chief Financial Officer
Dr. Srinivas Sidgiddi - Vice President, Research and Development
Ramsey Allous - General Counsel and Corporate Secretary
Conference Call Participants
Scott Henry - Alliance Global Partner
Kalpit - B. Riley Securities
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen only mode. [Operator Instructions]. A webcast replay of the call will be available approximately one hour after the end of the call for approximately 30 days.
I would now like to turn the call over to Jaclyn Jaffe, the company's Senior Director of Corporate Operations. Jaclyn, please go ahead.
Jaclyn Jaffe
Good afternoon and thank you for participating in today's conference call. Joining me from Journey Medical's leadership team are Claude Maraoui, Co-Founder, President and Chief Executive Officer, Joseph Benesch, Chief Financial Officer, Dr. Srinivas Sidgiddi, Vice President of Research and Development, and Ramsey Alloush, General Counsel and Corporate Secretary who will be joining for the Q&A portion of the call.
During this call, management will be making forward-looking statements, including statements that address, among other things, Journey Medical's expectations for future performance, operational results, financial condition, and the receipt of regulatory approvals.
Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Journey Medical's most recently filed to periodic reports on Form 10-K and Form 10-Q, the Form 8K filed with the SEC today and the company's press release that accompanies this call, particularly the cautionary statements in it.
Today's conference call includes non-GAAP financial measures that Journey Medical believes can be useful in evaluating its performance. You should not consider this additional information in isolation or as a substitute for results prepared in accordance with GAAP. For a reconciliation of this non-GAAP financial measure to net loss, its most directly comparable GAAP financial measure, please see the reconciliation table located in the company's earnings press release.
The content of this call contains time-sensitive information that is accurate only as of today, Monday, May 13, 2024, except as required by law, Journey Medical disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.